What do we do?
The Project Management Group comprises a Lab Director and a Programme Manager both with significant Pharmaceutical Industry management experience.
The Lab Director is responsible for the operation of the Core Laboratory’s functional groups (Genomics, Proteomics, Immuno Assay and Bioinformatics) ensuring timely delivery of workplans around TMRC Translational Programmes to agreed budgets. In addition, the Lab Director is responsible for maintaining leading edge capabilities at the Core Laboratory in terms of installed equipment base and best practices around sample extraction, storage and assay.
The Programme Manager is responsible for managing the operation, reporting and SRB review of ongoing Translational Programmes, project financials and scope changes. In addition, the Programme Manager is responsible for the contractual work around new Translational Programmes including contract definition, legal, financial and ethical review.
A Clinical Studies Manager provides expertise in the review of existing NHS consents and approvals pre-contract and assists the Principal Investigators in compiling new MREC submissions specific to approved Translational Programmes.
All functional groups are supported by two Administrative Assistants, one Porter and one Technical Assistant.
Meet the Team
|
|
Steve Moore, PhD, M.I.Biol
Lab Director
Wyeth Research
Phone: +44 (0) 1382 386350
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email
Steve Moore is the TMRC Lab Director. Prior to joining Wyeth, Steve was a senior investigator at GlaxoSmithKline where he led molecular neurobiology teams in discovery research identifying and validating targets in Neuroscience therapeutic areas, focusing on Alzheimers and MS and more recently the Gastroenterological Disease area, focusing on IBS, IBD and functional dyspepsia. Prior to his industry experience Steve enjoyed more than 20 years in academia with interests in neuronal plasticity as well as Muscular Dystrophy and mechanisms of muscle development.
Selected Publications |
|
|
Mark Beggs, PhD, MA (oxon)
Program Manager
Wyeth Research
Phone: +44 (0) 1382 386346
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email
Mark Beggs joined Wyeth in February 2007 as Programme Manager to manage TMRC’s elements of the overall Translational Medicine collaboration. Mark holds a Ph.D in Clinical Biochemistry and a BA in Biochemistry both from Oxford University and had previously spent eight years as Head of Consulting at The Automation Partnership in Cambridgeshire UK. Here he led a consulting team in delivering major change programmes for clients within Pharma Discovery and Biological production with particular focus on the application of manufacturing consultancy techniques in a Pharma Discovery environment. Two publicly citable projects on which he worked on at TAP were Wyeth’s new Screening Sciences project at Collegeville PA and GSK’s uHTS facility at Tres Cantos near Madrid. Mark has an additional ten year’s direct experience in Pharma Discovery, having worked variously for Glaxo in North Carolina USA, Zeneca in Alderley Park, UK and J and J in Beerse, Belgium. His last Pharma position was as Director of HTS for J and J in Belgium
Selected Publications |
|
|
Lindyanne Alexander, MSc, RGN
Clinical Studies Manager
University of Dundee
Phone: +44 (0) 1382 386461
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email
Lindyanne Alexander joined the TMRC in October 2008, coming from the Research and Development Office in NHS Tayside, where she was involved in the start up of commercial trials. Lindyanne qualified as a Registered General Nurse in 1987 and since then has attained a Post-Graduate Diploma in Clinical Research and more recently an MSc by Research, with a particular focus on the issues of recruitment and generalisability within Randomised Controlled Trials. Lindyanne has over 12 years experience of working in clinical research, previously working as Clinical Trials Co-ordinator for both Generation Scotland and the TOMBOLA trial.
Selected Publications |
